IndieBio to Give 8 Coronavirus-Tech Startups at Least $250,000 Each

aside.inlay.CoronaVirusCoverage.xlrg {
font-family: “Helvetica”, sans-serif;
text-transform: uppercase;
text-align: center;
border-width: 4px 0;
border-top: 2px solid #666;
border-bottom: 2px solid #666;
padding: 10px 0;
font-size: 18px;
font-weight: bold;
}
span.LinkHereRed {
color: #cc0000;
text-transform: uppercase;
font-family: “Theinhardt-Medium”, sans-serif;
}

IndieBio, the life sciences startup incubator that is part of venture firm SOSV, has opened applications to startups focused on developing “diagnostics, therapeutics, vaccines, disinfection, and other solutions addressing the worldwide problem of emerging infectious diseases.” And IndieBio is not just looking for solutions from biotech companies—startups involved in computing, automation, or, indeed, anybody with a technology that can address the problem, can apply.

Leave a Reply